NCT00701493View on ClinicalTrials.gov

A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

December 31, 2004

Conditions
Epilepsy
Interventions
DRUG

Topiramate oral liquid formulation;Topiramate Sprinkle formulation

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00701493 - A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults | Biotech Hunter | Biotech Hunter